keyword
https://read.qxmd.com/read/38406326/vitamin-k-infection-inflammation-and-auto-immunity
#21
REVIEW
Yuanyuan Xie, Shifang Li, Dinan Wu, Yining Wang, Jiepeng Chen, Lili Duan, Shuzhuang Li, Yuyuan Li
Vitamin K (VK) comprises a group of substances with chlorophyll quinone bioactivity and exists in nature in the form of VK1 and VK2. As its initial recognition originated from the ability to promote blood coagulation, it is known as the coagulation vitamin. However, based on extensive research, VK has shown potential for the prevention and treatment of various diseases. Studies demonstrating the beneficial effects of VK on immunity, antioxidant capacity, intestinal microbiota regulation, epithelial development, and bone protection have drawn growing interest in recent years...
2024: Journal of Inflammation Research
https://read.qxmd.com/read/38381650/structure-activity-relationship-studies-and-optimization-of-4-hydroxypyridones-as-gpr84-agonists
#22
JOURNAL ARTICLE
Loukas Ieremias, Mads H Kaspersen, Asmita Manandhar, Katrine Schultz-Knudsen, Christina Ioanna Vrettou, Rina Pokhrel, Christoffer V Heidtmann, Laura Jenkins, Christina Kanellou, Sara Marsango, Yueming Li, Hans Bräuner-Osborne, Elisabeth Rexen Ulven, Graeme Milligan, Trond Ulven
GPR84 is a putative medium-chain fatty acid receptor that is implicated in regulation of inflammation and fibrogenesis. Studies have indicated that GPR84 agonists may have therapeutic potential in diseases such as Alzheimer's disease, atherosclerosis, and cancer, but there is a lack of quality tool compounds to explore this potential. The fatty acid analogue LY237 ( 4a ) is the most potent GPR84 agonist disclosed to date but has unfavorable physicochemical properties. We here present a SAR study of 4a . Several highly potent agonists were identified with EC50 down to 28 pM, and with SAR generally in excellent agreement with structure-based modeling...
February 21, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38379184/associations-of-serum-insulin-and-related-measures-with-neuropathology-and-cognition-in-older-persons-with-and-without-diabetes
#23
JOURNAL ARTICLE
Zoe Arvanitakis, Ana W Capuano, Han Tong, Rupal I Mehta, Frederick Anokye-Danso, David A Bennett, Steven E Arnold, Rexford S Ahima
OBJECTIVE: To examine associations of serum insulin and related measures with neuropathology and cognition in older persons. METHODS: We studied 192 older persons (96 with diabetes and 96 without, matched by sex and balanced by age-at-death, education, and postmortem interval) from a community-based, clinical-pathologic study of aging, with annual evaluations including neuropsychological testing (summarized into global cognition and 5 cognitive domains) and postmortem autopsy...
February 20, 2024: Annals of Neurology
https://read.qxmd.com/read/38372266/cholesterol-a-friend-to-viruses
#24
REVIEW
Yingchun Wang, Lifen Gao
Cholesterol is a key life-sustaining molecule which regulates membrane fluidity and serves as a signaling mediator. Cholesterol homeostasis is closely related to various pathological conditions including tumor, obesity, atherosclerosis, Alzheimer's disease and viral infection. Viral infection disrupts host cholesterol homeostasis, facilitating their own survival. Meanwhile, the host cells strive to reduce cholesterol accessibility to limit viral infection. This review focuses on the regulation of cholesterol metabolism and the role of cholesterol in viral infection, specifically providing an overview of cholesterol as a friend to promote viral entry, replication, assembly, release and immune evasion, which might inspire valuable thinking for pathogenesis and intervention of viral infection...
February 19, 2024: International Reviews of Immunology
https://read.qxmd.com/read/38367649/elucidating-the-therapeutic-mechanism-of-hengqing-ii-decoction-in-alzheimer-s-disease-using-network-pharmacology-and-molecular-docking-techniques
#25
JOURNAL ARTICLE
Yajing Wang, Jiahui Jiang, Shuyu Chen, Qian Chen, Xiaojing Yan, Xiaozhong Shen
PURPOSE: The aim of our research was to investigate the mechanism of the Hengqing II decoction in treating Alzheimer's disease (AD) through network pharmacology and experimental validation methods. METHODS: Firstly, the major chemical compounds of Hengqing II decoction were characterized by ultra-high-performance liquid chromatography-high resolution mass spectrometry (UHPLC-Q-TOF-MS/MS), and the gene sets related to AD treatment by Hengqing II decoction were collected through the database of PubChem, Swiss TargetPrediction, and DisGeNET...
February 15, 2024: Fitoterapia
https://read.qxmd.com/read/38361373/berberine-a-multi-target-natural-pcsk9-inhibitor-with-the-potential-to-treat-diabetes-alzheimer-s-cancer-and-cardiovascular-disease
#26
JOURNAL ARTICLE
Caroline Coppinger, Briana Pomales, Mohammad Reza Movahed, Meredith Marefat, Mehrnoosh Hashemzadeh
Berberine is a natural product with a wide range of pharmacological effects. It has antimicrobial, anti-cancer, anti-inflammatory, anti-hyperlipidemic, neuroprotective, and cholesterollowering properties, among others. It has been used in traditional Chinese and Ayurvedic medicine for 3000 years and is generally well-tolerated with few side effects. Its main drawback is low oral bioavailability, which has hindered widespread clinical use. However, recent interest has surged with the emergence of evidence that berberine is effective in treating cancer, diabetes, Alzheimer's disease, and cardiovascular disease via multiple mechanisms...
January 25, 2024: Curr Rev Clin Exp Pharmacol
https://read.qxmd.com/read/38356470/recruitment-and-baseline-data-of-the-aging-and-cognitive-health-evaluation-in-elders-achieve-study-a-randomized-trial-of-a-hearing-loss-intervention-for-reducing-cognitive-decline
#27
JOURNAL ARTICLE
Nicholas S Reed, Lisa Gravens-Mueller, Alison R Huang, Adele M Goman, Christine M Mitchell, Michelle L Arnold, Spencer Bolton, Sheila Burgard, Theresa H Chisolm, David Couper, Jennifer A Deal, Joshua Evans, Sarah Faucette, Nancy W Glynn, Theresa Gmelin, Kathleen M Hayden, Elizabeth Miller, Melissa Minotti, Thomas Mosley, Stacee Naylor, James S Pankow, James Russell Pike, Victoria A Sanchez, Jennifer A Schrack, Josef Coresh, Frank R Lin
INTRODUCTION: Hearing loss is highly prevalent among older adults and independently associated with cognitive decline. The Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study is a multicenter randomized control trial (partially nested within the infrastructure of an observational cohort study, the Atherosclerosis Risk in Communities [ARIC] study) to determine the efficacy of best-practice hearing treatment to reduce cognitive decline over 3 years. The goal of this paper is to describe the recruitment process and baseline results...
2024: Alzheimer's & Dementia: Translational Research & Clinical Interventions
https://read.qxmd.com/read/38354820/integrated-analysis-and-separation-of-5-lipoxygenase-inhibitors-from-triterpenes-of-poria-cocos-using-bioaffinity-ultrafiltration-uplc-q-exactive-molecular-docking-and-target-based-multiple-complex-networks
#28
JOURNAL ARTICLE
Tong Wu, Wanchao Hou, Sainan Li, Chunming Liu, Yuchi Zhang
Poria cocos (Schw.) Wolf (P. cocos) has been widely used as medical plant in East Asia with remarkable anti-Alzheimer's disease (anti-AD) activity. However, the underlying mechanisms are still confused. In this study, based on the β-Amyloid deposition hypothesis of AD, an integrated analysis was conducted to screen and separation 5-lipoxygenase (5-LOX) inhibitors from triterpenoids of P. cocos and investigate the anti-AD mechanisms, containing bioaffinity ultrafiltration UPLC-Q-Exactive, molecular docking, and multiple complex networks...
February 12, 2024: Fitoterapia
https://read.qxmd.com/read/38339934/associations-between-mid-life-psychosocial-measures-and-estimated-late-life-amyloid-burden-the-atherosclerosis-risk-in-communities-aric-pet-study
#29
JOURNAL ARTICLE
Renee C Groechel, Albert C Liu, Silvia Koton, Anna M Kucharska-Newton, Pamela L Lutsey, Thomas H Mosley, Priya Palta, A Richey Sharrett, Keenan A Walker, Dean F Wong, Rebecca F Gottesman
BACKGROUND: Psychosocial factors are modifiable risk factors for Alzheimer's disease (AD). One mechanism linking psychosocial factors to AD risk may be through biological measures of brain amyloid; however, this association has not been widely studied. OBJECTIVE: To determine if mid-life measures of social support and social isolation in the Atherosclerosis Risk in Communities (ARIC) Study cohort are associated with late life brain amyloid burden, measured using florbetapir positron emission tomography (PET)...
February 7, 2024: Journal of Alzheimer's Disease: JAD
https://read.qxmd.com/read/38335908/effect-of-advanced-glycation-end-products-in-a-wide-range-of-medical-problems-including-covid-19
#30
REVIEW
Agnieszka Bronowicka-Szydełko, Kinga Gostomska-Pampuch, Aleksandra Kuzan, Jadwiga Pietkiewicz, Małgorzata Krzystek-Korpacka, Andrzej Gamian
Glycation is a physiological process that determines the aging of the organism, while in states of metabolic disorders it is significantly intensified. High concentrations of compounds such as reducing sugars or reactive aldehydes derived from lipid oxidation, occurring for example in diabetes, atherosclerosis, dyslipidemia, obesity or metabolic syndrome, lead to increased glycation of proteins, lipids and nucleic acids. The level of advanced glycation end-products (AGEs) in the body depends on rapidity of their production and the rate of their removal by the urinary system...
February 8, 2024: Advances in Medical Sciences
https://read.qxmd.com/read/38334236/emerging-functions-and-therapeutic-targets-of-il-38-in-central-nervous-system-diseases
#31
REVIEW
Yuan Gao, Luwei Cai, Yulu Wu, Min Jiang, Yidan Zhang, Wenjing Ren, Yirui Song, Lili Li, Ziguang Lei, Youzhuang Wu, Luwen Zhu, Jing Li, Dongya Li, Guohong Li, Chengliang Luo, Luyang Tao
Interleukin (IL)-38 is a newly discovered cytokine of the IL-1 family, which binds various receptors (i.e., IL-36R, IL-1 receptor accessory protein-like 1, and IL-1R1) in the central nervous system (CNS). The hallmark physiological function of IL-38 is competitive binding to IL-36R, as does the IL-36R antagonist. Emerging research has shown that IL-38 is abnormally expressed in the serum and brain tissue of patients with ischemic stroke (IS) and autism spectrum disorder (ASD), suggesting that IL-38 may play an important role in neurological diseases...
February 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38310439/intelligent-drug-delivery-pioneering-stimuli-responsive-systems-to-revolutionize-disease-management-an-in-depth-exploration
#32
JOURNAL ARTICLE
Badarinadh Kallepalli, Unnati Garg, Neha Jain, Rohan Nagpal, Sakshi Malhotra, Triveni Tiwari, Shreya Kaul, Upendra Nagaich
In recent years, there has been an escalating interest in stimuli-responsive drug delivery systems (SRDDS) due to their ability to revolutionize the delivery of therapeutics. SRDDSs offer a multitude of benefits in comparison to conventional drug delivery systems (DDS), including spatiotemporal control of drug release, targeted delivery, and improved therapeutic efficacy. The development of various classes of stimuli-responsive DDS, such as pH-responsive, temperature-responsive, photo-responsive, redox responsive systems, has been propelled by advances in materials science, nanotechnology, and biotechnology...
January 26, 2024: Current Drug Delivery
https://read.qxmd.com/read/38305581/natural-products-as-il-6-inhibitors-for-inflammatory-diseases-synthetic-and-sar-perspective
#33
REVIEW
Dipesh S Harmalkar, Aneesh Sivaraman, Hossam Nada, Joohan Lee, Hyeseul Kang, Yongseok Choi, Kyeong Lee
Interleukin-6 (IL-6), a pleiotropic cytokine, plays a pivotal role in the pathophysiology of various diseases including diabetes, atherosclerosis, Alzheimer's disease, multiple myeloma, rheumatoid arthritis, and prostate cancer. The signaling pathways associated with IL-6 offer promising targets for therapeutic interventions in inflammatory diseases and IL-6-dependent tumors. Although certain anti-IL-6 monoclonal antibodies are currently employed clinically, their usage is hampered by drawbacks such as high cost and potential immunogenicity, limiting their application...
February 2, 2024: Medicinal Research Reviews
https://read.qxmd.com/read/38284798/glyoxal-in-foods-formation-metabolism-health-hazards-and-its-control-strategies
#34
REVIEW
Mianzhang Zhang, Caihuan Huang, Juanying Ou, Fu Liu, Shiyi Ou, Jie Zheng
Glyoxal is a highly reactive aldehyde widely present in common diet and environment and inevitably generated through various metabolic pathways in vivo . Glyoxal is easily produced in diets high in carbohydrates and fats via the Maillard reaction, carbohydrate autoxidation, and lipid peroxidation, etc. This leads to dietary intake being a major source of exogenous exposure. Exposure to glyoxal has been positively associated with a number of metabolic diseases, such as diabetes mellitus, atherosclerosis, and Alzheimer's disease...
January 29, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38275217/the-role-of-atp-binding-cassette-transporter-g1-abcg1-in-alzheimer-s-disease-a-review-of-the-mechanisms
#35
REVIEW
Mohsen Karbasi Yazdi, Mohaddeseh Sadat Alavi, Ali Roohbakhsh
The maintenance of cholesterol homeostasis is essential for central nervous system function. Consequently, factors that affect cholesterol homeostasis are linked to neurological disorders and pathologies. Among them, ATP-binding cassette transporter G1 (ABCG1) plays a significant role in atherosclerosis. However, its role in Alzheimer's disease (AD) is unclear. There is inconsistent information regarding ABCG1's role in AD. It can increase or decrease amyloid β (Aβ) levels in animals' brains. Clinical studies show that ABCG1 is involved in AD patients' impairment of cholesterol efflux capacity (CEC) in the cerebrospinal fluid (CSF)...
January 26, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38240240/atherosclerosis-and-hippocampal-volumes-in-older-adults-the-role-of-age-and-blood-pressure
#36
JOURNAL ARTICLE
Alifiya Kapasi, Ana W Capuano, Melissa Lamar, Sue E Leurgans, Arnold M Evia, David A Bennett, Konstantinos Arfanakis, Julie A Schneider
BACKGROUND: Lower hippocampal volume is associated with late-life cognitive decline and is an important, but nonspecific marker for clinical Alzheimer's dementia. Cerebrovascular disease may also be associated with hippocampal volume. Here we study the role of intracranial large vessel disease (atherosclerosis) in association with hippocampal volume and the potential role of age, average late-life blood pressure across all visits, and other factors (sex, apolipoprotein ε4 [ APOE ε4], and diabetes)...
January 19, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38218331/the-role-of-irisin-in-kidney-diseases
#37
REVIEW
Xiejia Li, Bengt Lindholm
Irisin is a hormone that is produced mainly by skeletal muscles in response to exercise. It has been found to have a close correlation with obesity and diabetes mellitus for its energy expenditure and metabolic properties. Recent research has revealed that irisin also possesses anti-inflammatory, anti-oxidative and anti-apoptotic properties, which make it associated with major chronic diseases, such as chronic kidney disease (CKD), liver diseases, osteoporosis, atherosclerosis and Alzheimer s disease. The identification of irisin has not only opened up new possibilities for monitoring metabolic and non-metabolic diseases but also presents a promising therapeutic target due to its multiple biological functions...
January 11, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/38177294/significance-of-chitinase-3-like-protein-1-in-the-pathogenesis-of-inflammatory-diseases-and-cancer
#38
REVIEW
Ji Eun Yu, In Jun Yeo, Sang-Bae Han, Jaesuk Yun, Bongcheol Kim, Yoon Ji Yong, Young-Soo Lim, Tae Hun Kim, Dong Ju Son, Jin Tae Hong
Chitinase-3-like protein 1 (CHI3L1) is a secreted glycoprotein that mediates inflammation, macrophage polarization, apoptosis, and carcinogenesis. The expression of CHI3L1 is strongly upregulated by various inflammatory and immunological diseases, including several cancers, Alzheimer's disease, and atherosclerosis. Several studies have shown that CHI3L1 can be considered as a marker of disease diagnosis, prognosis, disease activity, and severity. In addition, the proinflammatory action of CHI3L1 may be mediated via responses to various proinflammatory cytokines, including tumor necrosis factor-α, interleukin-1β, interleukin-6, and interferon-γ...
January 4, 2024: Experimental & Molecular Medicine
https://read.qxmd.com/read/38175811/discovery-of-potent-orally-bioavailable-tricyclic-nlrp3-inhibitors
#39
JOURNAL ARTICLE
Juraj Velcicky, Philipp Janser, Nina Gommermann, Silke Brenneisen, Slavica Ilic, Eric Vangrevelinghe, Nikolaus Stiefl, Andreas Boettcher, Christelle Arnold, Claire Malinverni, Janet Dawson, Renata Murgasova, Sandrine Desrayaud, Karen Beltz, Alexandra Hinniger, Carien Dekker, Christopher J Farady, Angela Mackay
NLRP3 is a molecular sensor recognizing a wide range of danger signals. Its activation leads to the assembly of an inflammasome that allows for activation of caspase-1 and subsequent maturation of IL-1β and IL-18, as well as cleavage of Gasdermin-d and pyroptotic cell death. The NLRP3 inflammasome has been implicated in a plethora of diseases including gout, type 2 diabetes, atherosclerosis, Alzheimer's disease, and cancer. In this publication, we describe the discovery of a novel, tricyclic, NLRP3-binding scaffold by high-throughput screening...
January 4, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38167318/phytochemical-analysis-radical-scavenging-and-glioblastoma-u87-cells-toxicity-studies-of-stem-bark-of-buckthorn-rhamnus-pentapomica-r-parker
#40
JOURNAL ARTICLE
Yaseen Ur Rehman, Arshad Iqbal, Gowhar Ali, Ghallab Alotaibi, Alshebli Ahmed, Muhammad Ayaz
BACKGROUND: During the past two decades, the correlation between oxidative stress and a variety of serious illnesses such as atherosclerosis, chronic obstructive pulmonary disease (COPD), Alzheimer disease (AD) and cancer has been established. Medicinal plants and their derived phytochemicals have proven efficacy against free radicals and their associated diseases. The current work was aimed to evaluate the phytochemical constituents of Rhamnus pentapomica R. Parker via Gas Chromatography-Mass Spectrometry (GC-MS) and its antioxidant and anti-glioblastoma potentials...
January 2, 2024: BMC complementary medicine and therapies
keyword
keyword
56650
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.